GB8629567D0
(en)
*
|
1986-12-10 |
1987-01-21 |
Boots Co Plc |
Therapeutic agents
|
DE3887179T2
(de)
*
|
1987-03-02 |
1994-06-16 |
Brocades Pharma Bv |
Pharmazeutische Zusammensetzung, pharmazeutisches Granulat und Verfahren zu ihrer Herstellung.
|
JP2893191B2
(ja)
*
|
1988-11-08 |
1999-05-17 |
武田薬品工業株式会社 |
放出制御性マトリックス剤
|
US5085865A
(en)
*
|
1989-04-12 |
1992-02-04 |
Warner-Lambert Company |
Sustained release pharmaceutical preparations containing an analgesic and a decongestant
|
US5002774A
(en)
*
|
1989-06-08 |
1991-03-26 |
Erbamont, Inc. |
Sustained release pharmaceutical tablet
|
DE3927113C2
(de)
*
|
1989-08-17 |
1993-11-25 |
Dolorgiet Gmbh & Co Kg |
Mittel zur Behandlung von schweren Schmerzzuständen und Verfahren zu ihrer Herstellung
|
US5213807A
(en)
*
|
1990-05-03 |
1993-05-25 |
Chemburkar Pramod B |
Pharmaceutical composition containing ibuprofen and a prostaglandin
|
US5164398A
(en)
*
|
1991-04-01 |
1992-11-17 |
Merck & Co., Inc. |
Ibuprofen-antitussive combinations
|
GB9121204D0
(en)
*
|
1991-10-04 |
1991-11-20 |
Euro Celtique Sa |
Medicament
|
GB2260081B
(en)
*
|
1991-10-04 |
1995-11-29 |
Euro Celtique Sa |
Use of ibuprofen/codeine mixtures in treatment of chronic pain
|
US5266331A
(en)
*
|
1991-11-27 |
1993-11-30 |
Euroceltique, S.A. |
Controlled release oxycodone compositions
|
US5958459A
(en)
*
|
1991-12-24 |
1999-09-28 |
Purdue Pharma L.P. |
Opioid formulations having extended controlled released
|
US5968551A
(en)
|
1991-12-24 |
1999-10-19 |
Purdue Pharma L.P. |
Orally administrable opioid formulations having extended duration of effect
|
US5478577A
(en)
*
|
1993-11-23 |
1995-12-26 |
Euroceltique, S.A. |
Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
|
GB9203689D0
(en)
*
|
1992-02-20 |
1992-04-08 |
Euro Celtique Sa |
Pharmaceutical composition
|
JP3623805B2
(ja)
*
|
1992-02-20 |
2005-02-23 |
ユーロセルテイツク・エス・アー |
ヒドロモルホンスフェロイド調整放出製剤
|
ES2059260B1
(es)
*
|
1992-10-06 |
1995-04-16 |
Espanola Prod Quimicos |
Procedimiento de preparacion de comprimidos conteniendo diclofenaco; dispersables en agua.
|
US20080075781A1
(en)
*
|
1992-11-25 |
2008-03-27 |
Purdue Pharma Lp |
Controlled release oxycodone compositions
|
IL109460A
(en)
|
1993-05-10 |
1998-03-10 |
Euro Celtique Sa |
Controlled release formulation comprising tramadol
|
DE4318577A1
(de)
*
|
1993-06-04 |
1994-12-08 |
Merck Patent Gmbh |
Schmiermittelfreie, arzneimittelhaltige Tabletten
|
US20070275062A1
(en)
*
|
1993-06-18 |
2007-11-29 |
Benjamin Oshlack |
Controlled release oxycodone compositions
|
IL110014A
(en)
*
|
1993-07-01 |
1999-11-30 |
Euro Celtique Sa |
Solid controlled-release oral dosage forms of opioid analgesics
|
US7740881B1
(en)
|
1993-07-01 |
2010-06-22 |
Purdue Pharma Lp |
Method of treating humans with opioid formulations having extended controlled release
|
US5879705A
(en)
*
|
1993-07-27 |
1999-03-09 |
Euro-Celtique S.A. |
Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
|
FR2708611B1
(fr)
*
|
1993-07-29 |
1995-10-27 |
Meram Lab |
Sel de codéine de l'acide 2-(3-benzoylphényl)propionique, procédé d'obtention et compositions pharmaceutiques le contenant.
|
US6676967B1
(en)
|
1993-09-20 |
2004-01-13 |
Kos Pharmaceuticals, Inc. |
Methods for reducing flushing in individuals being treated with nicotinic acid for hyperlipidemia
|
US6080428A
(en)
|
1993-09-20 |
2000-06-27 |
Bova; David J. |
Nicotinic acid compositions for treating hyperlipidemia and related methods therefor
|
US6746691B2
(en)
|
1993-09-20 |
2004-06-08 |
Kos Pharmaceuticals, Inc. |
Intermediate release nicotinic acid compositions for treating hyperlipidemia having unique biopharmaceutical characteristics
|
US6818229B1
(en)
|
1993-09-20 |
2004-11-16 |
Kos Pharmaceuticals, Inc. |
Intermediate release nicotinic acid compositions for treating hyperlipidemia
|
US6210714B1
(en)
*
|
1993-11-23 |
2001-04-03 |
Euro-Celtique S.A. |
Immediate release tablet cores of acetaminophen having sustained-release coating
|
KR100354702B1
(ko)
*
|
1993-11-23 |
2002-12-28 |
유로-셀티크 소시에떼 아노뉨 |
약학조성물의제조방법및서방형조성물
|
US5891471A
(en)
*
|
1993-11-23 |
1999-04-06 |
Euro-Celtique, S.A. |
Pharmaceutical multiparticulates
|
US5843480A
(en)
*
|
1994-03-14 |
1998-12-01 |
Euro-Celtique, S.A. |
Controlled release diamorphine formulation
|
IT1270239B
(it)
*
|
1994-06-17 |
1997-04-29 |
Zambon Spa |
Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo
|
US5529787A
(en)
*
|
1994-07-07 |
1996-06-25 |
Alza Corporation |
Hydromorphone therapy
|
US5914131A
(en)
*
|
1994-07-07 |
1999-06-22 |
Alza Corporation |
Hydromorphone therapy
|
US6491945B1
(en)
*
|
1994-09-16 |
2002-12-10 |
Alza Corporation |
Hydrocodone therapy
|
GB9422154D0
(en)
*
|
1994-11-03 |
1994-12-21 |
Euro Celtique Sa |
Pharmaceutical compositions and method of producing the same
|
US5965161A
(en)
*
|
1994-11-04 |
1999-10-12 |
Euro-Celtique, S.A. |
Extruded multi-particulates
|
US5648358A
(en)
*
|
1996-03-05 |
1997-07-15 |
Mitra; Sekhar |
Compositions and methods for treating respiratory disorders
|
DK0914097T3
(da)
*
|
1996-03-12 |
2002-04-29 |
Alza Corp |
Sammensætning og doseringsform omfattende opioid antagonist
|
US5858409A
(en)
*
|
1996-04-17 |
1999-01-12 |
Fmc Corporation |
Hydrolyzed cellulose granulations for pharmaceuticals
|
US6348216B1
(en)
*
|
1996-06-10 |
2002-02-19 |
Knoll Pharmaceutical Company |
Ibuprofen and narcotic analgesic compositions
|
US6361794B1
(en)
|
1996-06-12 |
2002-03-26 |
Basf Corporation |
Method of making ibuprofen and narcotic analgesic composition
|
US5837292A
(en)
*
|
1996-07-03 |
1998-11-17 |
Yamanouchi Europe B.V. |
Granulate for the preparation of fast-disintegrating and fast-dissolving compositions containing a high amount of drug
|
US8022095B2
(en)
|
1996-08-16 |
2011-09-20 |
Pozen, Inc. |
Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs
|
GB9705989D0
(en)
*
|
1997-03-22 |
1997-05-07 |
Boots Co Plc |
Therapeutic composition
|
RS49982B
(sr)
*
|
1997-09-17 |
2008-09-29 |
Euro-Celtique S.A., |
Sinergistička analgetička kombinacija analgetičkog opijata i inhibitora ciklooksigenaze-2
|
CN1204890C
(zh)
*
|
1997-12-22 |
2005-06-08 |
欧罗赛铁克股份有限公司 |
防止阿片样物质滥用的方法
|
CA2314893C
(fr)
*
|
1997-12-22 |
2005-09-13 |
Euro-Celtique, S.A. |
Combinaison d'agonistes et d'antagonistes d'opioides
|
BR9910481A
(pt)
*
|
1998-06-11 |
2001-01-09 |
Upjohn Co |
Composição farmacêutica para comprimido de liberação não-contìnua
|
US6197347B1
(en)
|
1998-06-29 |
2001-03-06 |
Andrx Pharmaceuticals, Inc. |
Oral dosage for the controlled release of analgesic
|
US6806294B2
(en)
|
1998-10-15 |
2004-10-19 |
Euro-Celtique S.A. |
Opioid analgesic
|
DE19918325A1
(de)
|
1999-04-22 |
2000-10-26 |
Euro Celtique Sa |
Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
|
DE19927688A1
(de)
*
|
1999-06-17 |
2000-12-21 |
Gruenenthal Gmbh |
Mehrschichttablette zur Verabreichung einer fixen Kombination von Tramadol und Diclofenac
|
DE19927689A1
(de)
*
|
1999-06-17 |
2000-12-21 |
Gruenenthal Gmbh |
Orale Darreichungsformen zur Verabreichung einer fixen Kombination von Tramadol und Diclofenac
|
FI109453B
(fi)
*
|
1999-06-30 |
2002-08-15 |
Orion Yhtymae Oyj |
Farmaseuttinen koostumus
|
RU2230556C2
(ru)
|
1999-10-29 |
2004-06-20 |
Эро-Селтик, С.А. |
Препаративные формы гидрокодона с контролируемым высвобождением
|
BR0108379A
(pt)
|
2000-02-08 |
2002-11-05 |
Euro Celtique Sa |
Composições de liberação controlada contendo agonista e antagonista opióide, método para a preparação de uma formulação em dosagem de analgésico opióide de liberação controlada com potência analgésica aumentada e sistema de administração através da derme para um analgésico opióide
|
AU2002227383B2
(en)
|
2000-10-30 |
2004-07-08 |
Euro-Celtique S.A. |
Controlled release hydrocodone formulations
|
HUP0303178A3
(en)
*
|
2001-02-05 |
2008-03-28 |
R P Scherer Technologies |
Methods and compositions for reducing the taste of pharmaceutically active agents
|
UA81224C2
(uk)
*
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
DE60238756D1
(de)
|
2001-05-11 |
2011-02-10 |
Endo Pharmaceuticals Inc |
Opioid enthaltende arzneiform gegen missbrauch
|
US8329216B2
(en)
*
|
2001-07-06 |
2012-12-11 |
Endo Pharmaceuticals Inc. |
Oxymorphone controlled release formulations
|
CA2452872A1
(fr)
*
|
2001-07-06 |
2003-01-16 |
Endo Pharmaceuticals, Inc. |
Administration parenterale de 6-hydroxy-oxymorphone destinee a etre utilisee en tant qu'analgesique
|
AU2002316738B2
(en)
|
2001-07-18 |
2009-01-08 |
Euro-Celtique S.A. |
Pharmaceutical combinations of oxycodone and naloxone
|
DE60234057D1
(de)
|
2001-07-25 |
2009-11-26 |
Raptor Pharmaceutical Inc |
Zusammensetzungen und verfahren zur modulation des transports durch die blut-hirn-schranke
|
WO2003013433A2
(fr)
|
2001-08-06 |
2003-02-20 |
Euro-Celtique S.A. |
Formulations d'antagoniste sequestre
|
HUP0401191A3
(en)
|
2001-08-06 |
2006-11-28 |
Euro Celtique Sa |
Opioid agonist formulations with releasable and sequestered antagonist and process for their preparation
|
US20030044458A1
(en)
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
CA2459976A1
(fr)
*
|
2001-09-26 |
2003-04-03 |
Penwest Pharmaceuticals Company |
Formulations d'opioides presentant un potentiel reduit pour des utilisations abusives
|
EP1492506B2
(fr)
|
2002-04-05 |
2016-06-29 |
Euro-Celtique S.A. |
Matrice pour liberation prolongee, constante et independante de composes actifs
|
US6667100B2
(en)
*
|
2002-05-13 |
2003-12-23 |
Egc Enterprises, Inc. |
Ultra-thin flexible expanded graphite heating element
|
SI1551372T1
(en)
*
|
2002-09-20 |
2018-08-31 |
Alpharma Pharmaceuticals Llc |
SUBVENCATION DATA AND RELATED CONSTRUCTIONS AND PROCEDURES
|
US7090859B2
(en)
*
|
2002-12-13 |
2006-08-15 |
Ronald Thomas Haas |
Ketoprofen compositions and methods of making them
|
US20040166160A1
(en)
*
|
2003-01-14 |
2004-08-26 |
Ramkumar Subramanian |
Methods and dosage forms with modified viscosity layers
|
US20040202717A1
(en)
|
2003-04-08 |
2004-10-14 |
Mehta Atul M. |
Abuse-resistant oral dosage forms and method of use thereof
|
TWI347201B
(en)
*
|
2003-04-21 |
2011-08-21 |
Euro Celtique Sa |
Pharmaceutical products,uses thereof and methods for preparing the same
|
KR20060115860A
(ko)
*
|
2003-09-26 |
2006-11-10 |
알자 코포레이션 |
활성 제제의 서방성 전달을 위한 oros 푸시-스틱
|
WO2005030182A1
(fr)
*
|
2003-09-26 |
2005-04-07 |
Alza Corporation |
Formulations a liberation commandee presentant un taux croisssant de liberation
|
WO2005030181A1
(fr)
*
|
2003-09-26 |
2005-04-07 |
Alza Corporation |
Preparations a liberation regulee a base d'analgesiques opioides et non opioides
|
WO2005072079A2
(fr)
|
2003-09-26 |
2005-08-11 |
Alza Coporation |
Enrobage de medicaments a charge medicamenteuse elevee et procedes de fabrication
|
US20050079221A1
(en)
*
|
2003-10-10 |
2005-04-14 |
Groenewoud Pieter Jurjen |
Ibuprofen narcotic composition and method for making same
|
US20050266032A1
(en)
*
|
2003-12-17 |
2005-12-01 |
Sovereign Pharmaceuticals, Ltd. |
Dosage form containing multiple drugs
|
CA2562391A1
(fr)
*
|
2004-04-14 |
2005-10-27 |
Takeda Pharmaceutical Company Limited |
Preparation pharmaceutique solide
|
EP1604666A1
(fr)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioides pour le traitement de la bronchopneumopathie chronique obstructive
|
US8541026B2
(en)
|
2004-09-24 |
2013-09-24 |
Abbvie Inc. |
Sustained release formulations of opioid and nonopioid analgesics
|
EP1702558A1
(fr)
*
|
2005-02-28 |
2006-09-20 |
Euro-Celtique S.A. |
Procédé et dispositif pour évaluer la fonction de l'activité intestinale
|
EP1889198B1
(fr)
|
2005-04-28 |
2014-11-26 |
Proteus Digital Health, Inc. |
Systeme pharma-informatique
|
US9265732B2
(en)
|
2006-03-06 |
2016-02-23 |
Pozen Inc. |
Dosage forms for administering combinations of drugs
|
CN101410095B
(zh)
*
|
2006-03-06 |
2015-07-01 |
波曾公司 |
施用组合药物的剂型
|
US20070212414A1
(en)
*
|
2006-03-08 |
2007-09-13 |
Penwest Pharmaceuticals Co. |
Ethanol-resistant sustained release formulations
|
DK2526932T3
(en)
|
2006-06-19 |
2017-07-17 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
US8765178B2
(en)
*
|
2006-07-19 |
2014-07-01 |
Watson Laboratories, Inc. |
Controlled release formulations and associated methods
|
EP2068840A2
(fr)
*
|
2006-07-21 |
2009-06-17 |
LAB International SRL |
Système de délivrance hydrophobe empêchant les utilisations abusives
|
WO2008036682A2
(fr)
|
2006-09-18 |
2008-03-27 |
Raptor Pharmaceutical Inc. |
Traitement des troubles hépatiques par l'administration de conjugués de protéine associée au récepteur (rap)
|
GB0625646D0
(en)
*
|
2006-12-21 |
2007-01-31 |
Jagotec Ag |
Improvements in or relating to organic compounds
|
US20080305159A1
(en)
*
|
2007-06-06 |
2008-12-11 |
Mikart, Inc. |
Ibuprofen-Hydrocodone-Antihistamine Composition
|
US20090124650A1
(en)
*
|
2007-06-21 |
2009-05-14 |
Endo Pharmaceuticals, Inc. |
Method of Treating Pain Utilizing Controlled Release Oxymorphone Pharmaceutical Compositions and Instructions on Effects of Alcohol
|
GB0714790D0
(en)
*
|
2007-07-30 |
2007-09-12 |
Jagotec Ag |
Improvements in or relating to organic compounds
|
US8623418B2
(en)
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
US20090246276A1
(en)
|
2008-01-28 |
2009-10-01 |
Graham Jackson |
Pharmaceutical Compositions
|
US20090264454A1
(en)
*
|
2008-04-16 |
2009-10-22 |
Nickell Robert P |
Combined hydrocodone and analgesic formulation and method
|
WO2009130342A1
(fr)
|
2008-04-23 |
2009-10-29 |
Farmasierra Manufacturing, S.L. |
Préparation pharmaceutique améliorée à base d'ibuprofène et de codéine
|
DK3395372T3
(da)
|
2009-02-20 |
2022-04-19 |
Enhanx Biopharm Inc |
System til afgivelse af glutathion-baseret medikament
|
MX347106B
(es)
|
2009-03-10 |
2017-04-12 |
Euro-Celtique S A * |
Coposiciones farmacéuticas de liberación inmediata que comprenden oxicodona y naloxona.
|
ES2694506T3
(es)
|
2009-03-12 |
2018-12-21 |
Cumberland Pharmaceuticals Inc. |
Administración de ibuprofeno por vía intravenosa
|
EP2427178B1
(fr)
|
2009-05-06 |
2023-01-04 |
Laboratory Skin Care, Inc. |
Compositions pour libération dermique comprenant des complexes principe actif-particule de phosphate de calcium et procédés d'utilisation associés
|
US20130115250A1
(en)
*
|
2009-05-13 |
2013-05-09 |
Wyeth Llc |
Burst Drug Release Compositions
|
ES2365961B1
(es)
*
|
2010-03-30 |
2013-01-24 |
Farmasierra Manufacturing S.L. |
Formulación farmacéutica a base de ibuprofeno y codeína de estabilidad mejorada.
|
US20120077778A1
(en)
|
2010-09-29 |
2012-03-29 |
Andrea Bourdelais |
Ladder-Frame Polyether Conjugates
|
EP2694079B1
(fr)
*
|
2011-04-06 |
2018-01-17 |
Rutgers, The State University of New Jersey |
Polymères et procédés pour le traitement de la douleur
|
WO2013112456A1
(fr)
|
2012-01-24 |
2013-08-01 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Formulations à libération contrôlée destinées à l'induction et à la prolifération de cellules sanguines
|
US9072710B2
(en)
|
2012-03-16 |
2015-07-07 |
Cumberland Pharmaceuticals Inc. |
Injectable ibuprofen formulation
|
CA2918004C
(fr)
|
2013-07-23 |
2018-11-20 |
Euro-Celtique S.A. |
Combinaison d'oxycodone et de naloxone pour utilisation dans le traitement de la douleur chez des patients souffrant de douleur et d'une maladie entrainant une dysbiose intestinale et/ou l'augmentation du risque de translocation bacterienne intestinale
|
JP7174441B2
(ja)
*
|
2017-09-15 |
2022-11-17 |
クリスタルジェノミクス・インコーポレイテッド |
ポルマコキシブ及びトラマドールを含有する急性・慢性疼痛治療用薬剤学的組成物
|